Michael S. Ryan Inc’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Sell
126,006
-4,560
-3% -$95.1K 1.31% 15
2026
Q1
$2.73M Buy
130,566
+2,927
+2% +$61.8K 1.59% 13
2025
Q4
$2.7M Sell
127,639
-684
-0.5% -$14.5K 1.56% 14
2025
Q3
$2.72M Buy
128,323
+163
+0.1% +$3.43K 1.62% 14
2025
Q2
$2.7M Buy
128,160
+2,189
+2% +$45.2K 1.71% 13
2025
Q1
$2.61M Buy
125,971
+4,249
+3% +$87.2K 1.83% 13
2024
Q4
$2.48M Buy
121,722
+11,991
+11% +$248K 1.69% 17
2024
Q3
$2.33M Buy
109,731
+72,828
+197% +$1.52M 1.62% 17
2024
Q2
$749K Buy
36,903
+25,837
+233% +$521K 0.57% 22
2024
Q1
$227K Buy
+11,066
New +$226K 0.18% 45

Other funds holding IBDW

Michael S. Ryan Inc's IBDW Position: Q2 2026 in Review

Michael S. Ryan Inc reduced its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 3.5% in Q2 2026, selling an estimated $95.1K and leaving 126,006 shares worth $2.63M. The position accounts for 1.31% of the portfolio, ranked #15.

Michael S. Ryan Inc first reported a position in IBDW in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.73M in Q1 2026. 139 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Michael S. Ryan Inc held 126,006 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $2.63M as of Q2 2026.
  • Michael S. Ryan Inc sold 4,560 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $95.1K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 1.31% of Michael S. Ryan Inc's portfolio in Q2 2026, its #15 holding.
  • Michael S. Ryan Inc first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • Michael S. Ryan Inc's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $2.73M in Q1 2026.
  • 139 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Michael S. Ryan Inc's 13F filing for Q2 2026, filed 1 Jul 2026.